vedolizumab
takeda
['vedolizumab', 'vedo', ' vedo']
dr a pudipeddi: no difference in vedolizumab trough levels among patients who stopped imm vs those who had continued a trend towards more clinical relapse but not stat sig less fcp reduction #ddw2023 
I'm a Mayo specialist in evaluation and management of patients with ulcerative colitis and Crohn's disease. Tweets are mine. Retweet doesn't mean endorsement.